Skip to main content

Ryzolt FDA Approval History

FDA Approved: Yes (Discontinued) (First approved December 30, 2008)
Brand name: Ryzolt
Generic name: tramadol
Dosage form: Extended Release Tablets
Company: Purdue Pharma LP
Treatment for: Pain

Marketing Status: Discontinued

Ryzolt (tramadol extended release) is a once-daily analgesic indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time.

Development timeline for Ryzolt

DateArticle
Dec 31, 2008Approval Labopharm Announces FDA Approval of Once-Daily Ryzolt for Moderate to Moderately Severe Chronic Pain
Jul 17, 2008FDA Accepts Labopharm's Response for Once-Daily Tramadol asComplete Class 2 Response
Jul  3, 2008Labopharm Submits Complete Response to FDA as a Result of Outcomeof Appeal Process for Once-Daily Tramadol
Jun 30, 2008Labopharm Receives Response from FDA Regarding its Once-DailyTramadol Product
Apr  1, 2008Labopharm Appeals FDA's Decision on Once-Daily Tramadol to NextSupervisory Level After Additional Analysis Supports Efficacy
Jan 24, 2008Labopharm Receives FDA Response to Recent Appeal of ApprovableLetter For Once-Daily Tramadol
Oct 15, 2007Labopharm Appeals FDA's Decision on Once-Daily Tramadol
Sep 25, 2007Labopharm Provides Update on U.S. Regulatory Process for Once-DailyTramadol
Jun 29, 2007Labopharm Meets with FDA to Discuss Second Approvable Letter forOnce-daily Tramadol
Jun  1, 2007Labopharm Receives Second Approvable Letter from FDA for Once-DailyTramadol

See also

Ryzolt (tramadol) Consumer information

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer